Tirzepatide

Tirzepatide (LY3298176) is a synthetic research peptide classified as a dual receptor agonist, targeting the GLP-1 and GIP receptors. Evolve Peptides supplies it as lyophilized powder in 5 mg, 10 mg, 15 mg, 20 mg, 30 mg and 60 mg vials.

Every lot is third-party tested for identity and purity (99%+), and the certificate of analysis is shown on each product page. Orders ship from the U.S.

Tirzepatide vial sizes

What is Tirzepatide?

Tirzepatide mimics and enhances the effects of two naturally occurring incretin hormones, GLP-1 and GIP, which the gut releases in response to nutrient intake. In preclinical studies it is used to examine insulin signaling, energy balance and appetite regulation. It sits between Semaglutide, which targets the GLP-1 receptor alone, and Retatrutide, which adds the glucagon receptor.

The mechanism overview, references and current lot documentation are on each size’s page: Tirzepatide 5 mg, Tirzepatide 10 mg, Tirzepatide 15 mg, Tirzepatide 20 mg, Tirzepatide 30 mg, Tirzepatide 60 mg.

Research use only. Tirzepatide from Evolve Peptides is intended strictly for in vitro and preclinical research. It is not intended for human consumption, therapeutic use or diagnostic procedures.

Bestsellers:
SHOPPING BAG 0
RECENTLY VIEWED 0
Join Waitlist Enter your email address to be notified when this item is back in stock.
Evolve Peptides vials: BPC-157 + TB-500, GLP-2 TZ and GLP-1 S

Get 10% Off Your Next Order

Enter your email and we’ll send your code.

For research use only. Unsubscribe any time.

Check Your Inbox

Your 10% code is on its way.

Added to wishlist! VIEW WISHLIST